Chengdu Sino-Strong Pharmaceutical Co., Ltd.

Technology development and technology transfer of new drugs; production and sale of tablets, granules, dry mixed suspensions, hard capsules, and chemical raw materials (except dangerous goods); production of raw materials (dolasetron mesylate, rocuronium bromide, fasudil hydrochloride, agomelatine, esomeprazole, glycopyrrolate, tirofiban hydrochloride, levosimendan, prucalopride succinate, dabigatran etexilate mesylate, tauroursodeoxycholic acid, zofenopril, gefitinib, erlotinib hydrochloride, parecoxib sodium, penehyclidine hydrochloride); import and export of goods. (For projects that require approval according to law, business activities can only be carried out after approval by relevant departments).